Cases & Deals

  • Home
  • Practices
  • Cougar Biotechnology builds global patent portfolio for prostate cancer treatment

Share

Cougar Biotechnology builds global patent portfolio for prostate cancer treatment

February 2009

Client(s) Cougar Biotechnology, Inc.

On behalf of Cougar Biotechnology, Inc. Jones Day assisted with the development of its global patent portfolio related to the use of 17 alpha-hydroxylase/C17,20-lyase inhibitors to treat cancer.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.